20:0 Coenzyme A

FATTY ACID DERIVATIVES

CAT No.# CS-CC-00202
Category Fatty Acid Derivatives
CAS 799812-91-2
Stock Status
AVAILABLE ENQUIRE NOW View COA

(Available within 3-5 days)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.
Molecular Weight 1113.14
Molecular Formula C41H83N10O17P3S
Synonyms: ammonium (2S,3R,4S,5S)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-(((((((R)-3-hydroxy-4-((3-((2-(icosanoylthio)ethyl)amino)-3-oxopropyl)amino)-2,2-dimethyl-4-oxobutoxy)oxidophosphoryl)oxy)oxidophosphoryl)oxy)methyl)tetrahydrofuran-3-yl hydrogenphosphate
References: Ben-David, O., Y. Pewzner-Jung, O. Brenner, E.L. Laviad, A. Kogot-Levin, I. Weissberg, I.E. Biton, R. Pienik, E. Wang, S. Kelly, J. Alroy, A. Raas-Rothschild, A. Friedman, B. Brugger, A.H. Merrill Jr, and A.H. Futerman. (2011). Encephalopathy caused by ab??%?
Shipping: Free Shipping for worldwide on order above 2000 USD
20:0 Coenzyme A Worldwide Suppliers of 20:0 Coenzyme A Fatty Acid Derivatives Clearsynth CS-CC-00202

Product rating: 9 20:0 Coenzyme A based on 20 ratings

  1. Fatty Acid Derivatives
  2. 20:0 Coenzyme A


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. Aripiprazole (1042634)
20. 2-(p-Tolyl)pyrimidine


This page contains information about 20:0 Coenzyme A Cas 799812-91-2 and its Fatty Acid Derivatives.

20:0 Coenzyme A 20:0 Coenzyme A Worldwide Suppliers of 20:0 Coenzyme A Fatty Acid Derivatives Clearsynth 799812-91-2

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."